These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 17384667

  • 1. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    Verreth W, De Keyzer D, Davey PC, Geeraert B, Mertens A, Herregods MC, Smith G, Desjardins F, Balligand JL, Holvoet P.
    Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
    [Abstract] [Full Text] [Related]

  • 2. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H, Shi Y, Liu L, Sun A, Xu F, Chi J.
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [Abstract] [Full Text] [Related]

  • 3. Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.
    Desjardins F, Sekkali B, Verreth W, Pelat M, De Keyzer D, Mertens A, Smith G, Herregods MC, Holvoet P, Balligand JL.
    Eur Heart J; 2008 Jan; 29(1):128-37. PubMed ID: 18063594
    [Abstract] [Full Text] [Related]

  • 4. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.
    Circulation; 2004 Nov 16; 110(20):3259-69. PubMed ID: 15533870
    [Abstract] [Full Text] [Related]

  • 5. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 6. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M.
    Atherosclerosis; 2014 Jan 01; 232(1):40-51. PubMed ID: 24401215
    [Abstract] [Full Text] [Related]

  • 7. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    Li Y, Wang Q, Zhou J, Xu Q, Chu X, Sun T, Liu X, Cai S.
    Eur J Pharmacol; 2014 Jan 15; 723():23-8. PubMed ID: 24333476
    [Abstract] [Full Text] [Related]

  • 8. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
    Shimizu T, Miura S, Tanigawa H, Kuwano T, Zhang B, Uehara Y, Saku K.
    Arterioscler Thromb Vasc Biol; 2014 Oct 15; 34(10):2246-53. PubMed ID: 25104799
    [Abstract] [Full Text] [Related]

  • 9. Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque.
    Kaneko K, Saito H, Takahashi T, Kiribayashi N, Omi K, Sasaki T, Niizeki T, Sugawara S, Akasaka M, Kubota I.
    J Stroke Cerebrovasc Dis; 2014 Jul 15; 23(6):1682-9. PubMed ID: 24739590
    [Abstract] [Full Text] [Related]

  • 10. Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and THP-1 cells.
    Holvoet P, Davey PC, De Keyzer D, Doukouré M, Deridder E, Bochaton-Piallat ML, Gabbiani G, Beaufort E, Bishay K, Andrieux N, Benhabilès N, Marguerie G.
    Arterioscler Thromb Vasc Biol; 2006 Jul 15; 26(7):1558-65. PubMed ID: 16690872
    [Abstract] [Full Text] [Related]

  • 11. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN, Tao LJ, Zhou J, Wang R, Lu MM, Fu X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug 15; 39(8):743-8. PubMed ID: 22169423
    [Abstract] [Full Text] [Related]

  • 12. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.
    Monetti M, Canavesi M, Camera M, Parente R, Paoletti R, Tremoli E, Corsini A, Bellosta S.
    Pharmacol Res; 2007 May 15; 55(5):441-9. PubMed ID: 17350858
    [Abstract] [Full Text] [Related]

  • 13. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT, Cao Y, Wang TQ, Wang LJ, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ.
    Eur J Pharmacol; 2011 Jan 10; 650(1):275-84. PubMed ID: 20854809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.
    Cardiovasc Res; 2009 May 01; 82(2):371-81. PubMed ID: 19176597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
    Verreth W, Ganame J, Mertens A, Bernar H, Herregods MC, Holvoet P.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):922-8. PubMed ID: 16456093
    [Abstract] [Full Text] [Related]

  • 19. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
    Enomoto S, Sata M, Fukuda D, Nakamura K, Nagai R.
    Biomed Pharmacother; 2009 Jan 01; 63(1):19-26. PubMed ID: 18162361
    [Abstract] [Full Text] [Related]

  • 20. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
    Holvoet P.
    Verh K Acad Geneeskd Belg; 2008 Jan 01; 70(3):193-219. PubMed ID: 18669160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.